Inhalation Sciences receives new order worth 62 000 EURO from University of Vienna

(Stockholm, 16 September 2022) Inhalation Sciences AB (ISAB) has received a new order from prestigious returning client the Department of Pharmaceutical Technology and Biopharmaceutics at the University of Vienna for the advanced in vitro cell exposure module XposeALI^®.

The client previously purchased ISAB’s aerosol generation platform PreciseInhale^®, in November 2020, plus two in vivo exposure modules. PreciseInhale^® and its suite of advanced exposure modules can generate voluminous high-precision data through all phases of preclinical research, from in vitro to in vivo, from even tiny amounts of test substance.

Now the Department is complementing its PreciseInhale^® suite with ISAB’s advanced 3D cell exposure module XposeALI^® for a total order value of 62 000 Euros. Unlike previous cell exposure systems - where cells are immersed in a liquid - XposeALI^® enables the study of the permeability of substances in an Air-Liquid Interface - a more physiological approach that mimics the conditions and processes occurring in the lungs.

ISAB CEO Manoush Masarrat: “We’re very pleased that the expert team at the University of Vienna are now complementing their PreciseInhale^® system with our unique cell exposure module XposeALI^®. This is a purchase that shows clearly the advanced precision and capabilities of our equipment – and how it can grow and keep delivering to research teams and organizations to meet all their inhalation research needs.”

To read more about XposeALI^® go here.